Cowen & Co. Recent News
A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Fed Speakers
All The Sell-Side Ratings And Price Targets On Walmart Ahead Of Q2 Earnings
A Peek Into The Markets: U.S. Stock Futures Flat; Citigroup Earnings In Focus
Analyst: Kite Pharma's CAR-T Patient Death, Stock Selloff Is A Buying Opportunity
Analyst Sentiment On Tesla So Far In 2017
What's With Wall Street's Lofty Price Targets On Intercept?
Hemophilia Fighter Bioverativ Launches On NASDAQ
Cowen Boosts Alphabet Price Target To $1,050
Viridian's President: If Federally Legal, The U.S. Cannabis Market Could Surpass $100 Billion Per Year
All The Analyst Ratings And Price Targets Ahead Of Salesforce.com's Q3 Earnings
How The Street Responded To AT&T's Mega-Deal For Time Warner
In The Beauty Industry, E.L.F. Is Looking Attractive
Nike Continues To Build A Moat Around Its Brand
5 In Focus: Loop Capital Analysts Railroad Stocks Following Wednesday's Conferences
Tractor Supply Hit With A Slew Of Sell-Side Downgrades As Guidance Disappoints
2 Debates Heading Into Online Travel Earnings
What's Biomed Realty Worth In A Buyout?
Cowen: An Acquisition 'Seems Likely' At Avolon, Stock Less Attractive
Is Expedia Still A Buy? Wall Street Analysts Weigh In
One Of The Market's Biggest Healthcare REITs: Should You Buy?
Why Raymond James Downgraded Potash: Not The First To See Red Flags?
Cowen Downgrades Apple, Highlights Several Concerns Following Q3 Results
Cowen On Micron-Tsinghua Deal: 'Wow.'